<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><image><url>http://www.searchbreast.com/templates/Default/img/logo.gif</url><title>eSyndiCat Directory 2.2 :: Powered by eSyndiCat Pro 2.2</title><link>http://www.searchbreast.com/</link></image><title>Clinical Trials</title><description></description><link>http://www.searchbreast.com/clinical-trials/</link><item><title>Breast Cancer Clinical Trials</title><link>http://www.searchbreast.com/clinical-trials/Breast-Cancer-Clinical-Trials-l21.html</link><description>
Breast cancer clinical trials evaluate the effectiveness and safety of medications or treatments by monitoring their effects on large groups of people.
</description></item><item><title>Clinical Trials for Breast Cancer at Mayo Clinic</title><link>http://www.searchbreast.com/clinical-trials/Clinical-Trials-for-Breast-Cancer-at-Mayo-Clinic-l25.html</link><description>Mayo&#039;s clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide.
</description></item><item><title>ScienceDaily: International Trial Of Novel Breast Cancer Drug</title><link>http://www.searchbreast.com/clinical-trials/ScienceDaily-International-Trial-Of-Novel-Breast-Cancer-Drug-l22.html</link><description>A clinical trial of a new targeted breast cancer drug, led by physicians at Massachusetts General Hospital (MGH) Cancer Center, has begun enrolling patients.
</description></item><item><title>Switching Breast Cancer Drugs Reduces Relapse</title><link>http://www.searchbreast.com/clinical-trials/Switching-Breast-Cancer-Drugs-Reduces-Relapse-l23.html</link><description>An international trial has shown that switching from tamoxifen to exemestane afer 2 to 3 years increases disease-free survival and shows a slightly reduced risk of death for women treated for early stage hormone-sensitive breast cancer.
</description></item></channel></rss>